Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury
Afyonkarahisar Health Sciences University
60 participants
Nov 15, 2022
INTERVENTIONAL
Conditions
Summary
The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury. In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain. In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.
Eligibility
Inclusion Criteria5
- Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury and
- Having spinal cord injury with neurophatic pain at least six months ago,
- Able to follow two-stage verbal commands,
- Agreeing to participate in the study voluntarily and regularly,
- Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study.
Exclusion Criteria14
- Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension,
- Epilepsy,
- History of antiepileptic drug use,
- Intracranial metal object,
- Presence of in-ear implant,
- Cognitive dysfunction,
- Lower extremity peripheral nerve injury,
- With malignancy and active infection,
- Infection on the skin in the application area,
- Having an open wound,
- Having inflammatory disease,
- Orthopedic injuries that can limit maximum effort contractions,
- Having a brain lesion or a history of drug use that will affect the seizure threshold,
- Patients with increased intracranial pressure or uncontrolled migraine will not be included.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
It was planned to apply a total of 1200 beats to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.
It was planned to apply a to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05645003